Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

1(20%)

Results Posted

75%(3 trials)

Phase Distribution

Ph phase_1

20%

Ph phase_2

80%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 1Safety & dosage

1(20.0%)

Phase 2Efficacy & side effects

4(80.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(4)

Detailed Status

Completed4

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 11 (20.0%)

Phase 24 (80.0%)

Trials by Status

completed480%

recruiting120%

Recent Activity

1 active trials

Showing 5 of 5

recruitingphase_2

Longitudinal MR Imaging of Pulmonary Function in Patients Receiving Thoracic Radiation Treatment

NCT02478255

completedphase_1

Using MRI to Visualize Regional Therapy Response in Idiopathic Pulmonary Fibrosis

NCT02478268

Clinical Trials (5)

Showing 5 of 5 trials

NCT01280994Phase 2

Hyperpolarized 129Xe MRI for Imaging Pulmonary Function

Recruiting

NCT04828135Phase 2

Dual MRI for Cardiopulmonary COVID-19 Long Haulers

Completed

NCT03367312Phase 2

Assessing Response to Inhaled Prostacyclin With Hyperpolarized Xe MRI

Completed

NCT02478255Phase 2

Longitudinal MR Imaging of Pulmonary Function in Patients Receiving Thoracic Radiation Treatment

Completed

NCT02478268Phase 1

Using MRI to Visualize Regional Therapy Response in Idiopathic Pulmonary Fibrosis

Completed

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5